Clinical Trial Update: SCGs as a Proxy for Determining the Cognitive Status of Older Adults

View source ↗

Summary

The trial evaluating SCGs as a proxy for determining cognitive status in older adults has completed; the snippet does not report specific results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: University of Alberta | Conditions: Mild Cognitive Impairment, Dementia | Status: COMPLETED